Hyphens Pharma International (SGX:1J5) Total Equity: S$67.1 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGX:1J5 Hyphens Pharma International Ltd SGX:1J5
82 GF Score
Price S$0.36
GF Value S$0.31
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Hyphens Pharma International Total Equity?

Hyphens Pharma International SGX:1J5 -2.70% 82 Total Equity is S$67.1 Mil as of Jun. 2026. GuruFocus rates SGX:1J5 with a GF Score™ of 82/100 and a GF Value™ of S$0.31 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Hyphens Pharma International's total equity for the quarter that ended in Jun. 2026 was S$67.1 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Hyphens Pharma International Total Equity Historical Data

* Premium members only.

The historical data trend for Hyphens Pharma International's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hyphens Pharma International Total Equity Chart

Hyphens Pharma International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.74 70.27 65.86 74.47 72.57

Hyphens Pharma International Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.16 74.47 67.72 72.57 67.07
SGX:1J5
82GF Score
Hyphens Pharma International Ltd SGX:1J5
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hyphens Pharma International Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Hyphens Pharma International's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=123.595-51.027
=72.6

Hyphens Pharma International's Total Equity for the quarter that ended in Jun. 2026 is calculated as

Total Equity=Total Assets(Q: Jun. 2026 )-Total Liabilities(Q: Jun. 2026 )
=121.648-54.575
=67.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of S$67.1 Mil mean?
Hyphens Pharma International (SGX:1J5) has a Total Equity of S$67.1 Mil as of Jun. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Hyphens Pharma International and its competitors.
Is Hyphens Pharma International's Total Equity too high?
Hyphens Pharma International's current Total Equity is S$67.1 Mil. Overall, Hyphens Pharma International has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hyphens Pharma International's Total Equity compare to MCK and COR?
Hyphens Pharma International's Total Equity of S$67.1 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Distribution company?
A good Total Equity depends on the Medical Distribution industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Hyphens Pharma International and its competitors. Hyphens Pharma International's current Total Equity is S$67.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hyphens Pharma International stock overvalued right now?
Based on GuruFocus' analysis, Hyphens Pharma International (SGX:1J5) is currently considered Modestly Overvalued. The stock's GF Value™ is S$0.31, compared to a current price of S$0.36 — trading 16.1% above its estimated fair value. The current Total Equity is S$67.1 Mil. Hyphens Pharma International's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Hyphens Pharma International (SGX:1J5), the current Total Equity is S$67.1 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hyphens Pharma International (SGX:1J5) Overvalued in 2026?

Based on GuruFocus' analysis, Hyphens Pharma International stock appears to be overvalued. The current stock price of S$0.36 is trading 16.1% above its estimated GF Value™ of S$0.31. GuruFocus considers Hyphens Pharma International to be Modestly Overvalued.

Key valuation signals for SGX:1J5:

  • Total Equity: S$67.1 Mil
  • GF Value™: S$0.31 vs. price of S$0.36 (16.1% above fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the SGX:1J5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hyphens Pharma International Business Description

Address 16 Tai Seng Street, Level 4, Singapore, SGP, 534138
Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include the Pharmaceutical and Medical Aesthetics segment; Proprietary Brands segment; and Digital Platform and E-Pharmacy segment. The Pharmaceutical and Medical Aesthetics segment engages in the business of marketing and selling a range of pharmaceutical and medical aesthetics products with exclusivity in the relevant ASEAN countries. The Proprietary Brands segment develops, markets, and sells dermatological, pharmaceuticals and health supplement products. The Digital Platform and E-Pharmacy segment is a digital platform servicing procurement needs of healthcare professionals, healthcare institutions, and retail pharmacies, mainly in Singapore.
82GF Score

Get the complete analysis for SGX:1J5

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.36
Price
S$0.31
GF Value